JPRN-UMIN000001691招募中2 期
Phase II study of prophylactic oral administration of diltiazem for atrial fibrillation after lung resection - Prophylactic administration of diltiazem for atrial fibrillation after lung resection
Department of Surgical Oncology, Hokkaido University Graduate School of Medicine0 个研究点目标入组 124 人开始时间: 2009年2月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 124
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •unstable angina pectoris, myocardial infarction or heart failure with in 3 months uncontrolled diabetes or hypertension active infection gastrointestinal bleeding diarrhea ileus chronic Af already taking diltiazem or other calcium blocker AV block more than 2nd degree sick sinus syndrome past history of severe allergy uncontrolled pleural effusion, ascites or pericardial fluid in pregnancy
研究者
相似试验
已完成
2 期
Phase IIa examination of the effect of oral dosing of NV-52 on surrogate markers of inflammatory bowel disease (IBD) in patients with stable disease but with a consistent abnormality in one or more surrogate marker.ACTRN12607000617460ovogen Research Pty Ltd10
进行中（未招募）
1 期
A Study of Prednisolone in Patients with Early (within 3 years of onset) Diffuse Cutaneous Scleroderma (Systemic Sclerosis)Early diffuse cutaneous systemic sclerosisMedDRA version: 20.0Level: LLTClassification code 10012977Term: Diffuse systemic sclerosisSystem Organ Class: 100000004859EUCTR2016-002651-25-GBResearch Governance and Integrity, University of Manchester72
进行中（未招募）
不适用
A phase II study of orally administered RO4929097, a gamma-secretase inhibitor, as a single agent in patients with recurrent or refractory Non-Small Cell Lung Cancer (NSCLC).Patients with recurrent or refractory stage IIIB/IV NSCLC.MedDRA version: 9.1Level: LLTClassification code 10029515Term: Non-small cell lung cancer recurrentMedDRA version: 9.1Level: LLTClassification code 10029521Term: Non-small cell lung cancer stage IIIBMedDRA version: 9.1Level: LLTClassification code 10029522Term: Non-small cell lung cancer stage IVEUCTR2008-006384-37-NLF. Hoffmann-La Roche Ltd
已完成
2 期
Phase II study of the effectiveness of prophylaxis against side effects associated with Afatinib (NLCTG 1401)non-small cell lung cancerJPRN-UMIN000016167iigata Lung Cancer Treatment Group30
已完成
1 期
A phase I/II clinical trial of prophylactic extended-field radiotherapy of pelvic and para-aortic lymph nodes in locally advanced squamous cell carcinoma of the uterine cervix using carbon-ion beamsuterine cervical cancerJPRN-UMIN000016169ational Institute of Radiological Sciences20